Total assets grew to $16.9B in 2026Q2, but goodwill of $9.1B (over half of assets) and debt-to-equity of 0.82 indicate acquisition-driven expansion and potential impairment risk, though the current ratio improved to 1.59 from 0.97 in 2024Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 2.84B | 2.38B | 2.39B | 2.37B | 1.9B | 2.74B | 3.06B | 2.49B | 1.39B | 1.31B | 1.53B | 1.5B | 1.6B | 1.38B | 1.56B | 1.4B | 1.61B | 1.68B | 1.5B | 1.37B | 1.19B | 1.07B | 931.08M | 995.79M | 824.44M | 876.51M | 980.69M | 872.7M | 578.2M | 571.9M | 510.96M |
| Cash & Short-Term Investments | 626M | 420M | 549M | 686M | 315M | 872M | 1.16B | 1.19B | 135M | 137M | 359M | 133M | 192M | 187M | 295.6M | 164.9M | 449.3M | 534.3M | 253.9M | 167.59M | 149.64M | 92.13M | 73.3M | 154.96M | 96.78M | 122.33M | 171.48M | 27.3M | 202.9M | 161.7M | 41.96M |
| Cash Only | 626M | 420M | 549M | 686M | 315M | 872M | 1.16B | 1.19B | 135M | 137M | 359M | 133M | 192M | 187M | 295.6M | 164.9M | 449.3M | 534.3M | 253.9M | 167.59M | 149.64M | 92.13M | 73.3M | 154.96M | 96.78M | 122.33M | 171.48M | 27.3M | 202.9M | 161.7M | 41.96M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.67B | 1.41B | 1.3B | 1.21B | 1.2B | 1.44B | 1.52B | 1.06B | 1.01B | 924M | 926M | 901M | 932M | 852M | 867M | 906.46M | 845.3M | 827.34M | 832.87M | 881.97M | 774.41M | 732.91M | 649.28M | 609.19M | 522.13M | 508.34M | 485.57M | 539.26M | 220.9M | 238.4M | 297.74M |
| Days Sales Outstanding | 48.29 | 46.57 | 48.21 | 47.74 | 44.13 | 48.65 | 58.79 | 50.22 | 49.05 | 43.75 | 44.98 | 43.89 | 45.75 | 43.52 | 42.87 | 44.05 | 41.87 | 40.51 | 41.93 | 48.01 | 45.09 | 48.61 | 46.23 | 46.93 | 46.39 | 51.15 | 51.81 | 89.26 | 55.28 | 56.92 | 67.24 |
| Inventory | 233M | 189M | 188M | 190M | 192M | 208M | 223M | 123M | 99M | 95M | 82M | 84M | 110M | 91M | 93.1M | 89.1M | 76.6M | 91.4M | 102.1M | 95.23M | 78.56M | 77.94M | 75.33M | 72.48M | 60.9M | 49.91M | 44.27M | 52.3M | 31.2M | 30.4M | 28.52M |
| Days Inventory Outstanding | 9.84 | 9.18 | 10.35 | 11.19 | 10.87 | 11.54 | 14.02 | 8.91 | 7.34 | 7.35 | 6.48 | 6.58 | 8.66 | 7.68 | 7.79 | 7.4 | 6.48 | 7.72 | 8.76 | 8.76 | 7.76 | 8.73 | 9.19 | 9.56 | 9.14 | 8.47 | 8.21 | 14.47 | 13.99 | 12.67 | 10.3 |
| Other Current Assets | 319M | 361M | 351M | 286M | 196M | 187M | 0 | 0 | 0 | 0 | 9M | 176M | 183M | 148M | 214M | 153.33M | 142.47M | 131.8M | 218.42M | 149.84M | 120.54M | 107.44M | 83.03M | 108.97M | 102.7M | 157.65M | 279.37M | 253.82M | 123.2M | 141.4M | 129.06M |
| Total Non-Current Assets | 14.1B | 13.85B | 13.76B | 11.65B | 10.94B | 10.87B | 10.97B | 10.35B | 9.61B | 9.2B | 8.57B | 8.46B | 8.27B | 7.57B | 7.72B | 7.91B | 6.92B | 6.88B | 6.91B | 7.19B | 4.47B | 4.24B | 3.27B | 3.31B | 2.5B | 2.05B | 1.88B | 2.01B | 782M | 829M | 884.1M |
| Property, Plant & Equipment | 2.9B | 2.86B | 2.76B | 2.42B | 2.35B | 2.3B | 2.23B | 1.97B | 1.29B | 1.15B | 1.03B | 925M | 933M | 805M | 755.8M | 799.8M | 834.4M | 825.9M | 879.7M | 912M | 752.36M | 753.66M | 619.49M | 607.3M | 570.15M | 508.62M | 449.86M | 428M | 240.4M | 250.2M | 287.75M |
| Fixed Asset Turnover | 4.05x | 3.86x | 3.57x | 3.83x | 4.20x | 4.68x | 4.23x | 3.92x | 5.85x | 6.73x | 7.30x | 8.10x | 7.97x | 8.88x | 9.77x | 9.39x | 8.83x | 9.03x | 8.24x | 7.35x | 8.33x | 7.30x | 8.28x | 7.80x | 7.21x | 7.13x | 7.61x | 5.15x | 6.07x | 6.11x | 5.62x |
| Goodwill | 9.11B | 8.95B | 8.86B | 7.73B | 7.22B | 7.09B | 6.87B | 6.62B | 6.56B | 6.33B | 6B | 5.91B | 6.03B | 5.65B | 5.54B | 5.8B | 5.1B | 5.08B | 5.05B | 5.22B | 3.39B | 3.2B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.67B | 1.64B | 1.76B | 1.17B | 1.09B | 1.17B | 1.17B | 1.12B | 1.21B | 1.12B | 949M | 984M | 1.07B | 896M | 872.2M | 1.04B | 796.4M | 823.7M | 827.4M | 886.73M | 193.35M | 147.38M | 2.52B | 2.54B | 1.81B | 1.38B | 1.26B | 1.44B | 494.7M | 513.8M | 297.74M |
| Long-Term Investments | 544M | 136M | 123M | 135M | 132M | 141M | 521M | 482M | 436M | 462M | 443M | 473M | 46M | -148M | -174.21M | 0 | 0 | 0 | -218.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 277M | 270M | 255M | 198M | 144M | 163M | 176M | 160M | 119M | 132M | 116M | 174M | 238M | 215M | 559M | 281M | 189.5M | 150.7M | 145M | 172.5M | 133.72M | 138.34M | 105.44M | 112.84M | 88.92M | 113.6M | 172.39M | 141.9M | 46.9M | 65M | 29.48M |
| Total Assets | 16.94B | 16.23B | 16.15B | 14.02B | 12.84B | 13.61B | 14.03B | 12.84B | 11B | 10.5B | 10.1B | 9.96B | 9.88B | 8.95B | 9.28B | 9.31B | 8.53B | 8.56B | 8.4B | 8.57B | 5.66B | 5.31B | 4.2B | 4.3B | 3.32B | 2.93B | 2.86B | 2.88B | 1.36B | 1.4B | 1.4B |
| Asset Turnover | 0.70x | 0.68x | 0.61x | 0.66x | 0.77x | 0.79x | 0.67x | 0.60x | 0.68x | 0.73x | 0.74x | 0.75x | 0.75x | 0.80x | 0.80x | 0.81x | 0.86x | 0.87x | 0.86x | 0.78x | 1.11x | 1.04x | 1.22x | 1.10x | 1.24x | 1.24x | 1.19x | 0.77x | 1.07x | 1.09x | 1.16x |
| Asset Growth % | 12.7% | 0.45% | 15.2% | 9.23% | -5.69% | -2.96% | 9.21% | 16.72% | 4.76% | 3.99% | 1.39% | 0.86% | 10.38% | -3.62% | -0.32% | 9.21% | -0.42% | 1.9% | -1.89% | 51.3% | 6.7% | 26.22% | -2.27% | 29.4% | 13.43% | 2.3% | -0.49% | 111.62% | -2.91% | 0.42% | - |
| Total Current Liabilities | 1.79B | 2.28B | 2.17B | 1.81B | 1.55B | 1.75B | 1.78B | 1.99B | 1.49B | 1.06B | 981M | 1.17B | 1.71B | 1.13B | 1.05B | 1.56B | 1.21B | 1.06B | 1.22B | 1.29B | 1.15B | 1.1B | 1.04B | 723.8M | 635.98M | 658.62M | 954.99M | 701.2M | 309.5M | 295.1M | 249.43M |
| Accounts Payable | 0 | 1.6B | 287M | 378M | 324M | 357M | 446M | 263M | 222M | 224M | 261M | 279M | 257M | 258M | 203.55M | 215.34M | 212.49M | 207.33M | 191.22M | 205.07M | 215.72M | 193.38M | 668.99M | 649.85M | 609.95M | 657.22M | 689.58M | 626.49M | 242.3M | 244.9M | 206.7M |
| Days Payables Outstanding | 53.81 | 77.74 | 15.8 | 22.26 | 18.33 | 19.81 | 28.05 | 19.06 | 16.45 | 17.33 | 20.64 | 21.87 | 20.23 | 21.77 | 17.02 | 17.88 | 17.97 | 17.51 | 16.4 | 18.85 | 21.3 | 21.67 | 81.65 | 85.67 | 91.53 | 111.49 | 127.92 | 173.36 | 108.66 | 102.1 | 74.63 |
| Short-Term Debt | 190M | 678M | 937M | 585M | 247M | 269M | 296M | 1.04B | 562M | 107M | 6M | 159M | 518M | 212M | 9.4M | 654.39M | 349M | 170.51M | 5.14M | 163.58M | 316.87M | 336.84M | 374.8M | 73.95M | 26.03M | 1.4M | 265.41M | 45.4M | 51.4M | 32.6M | 20.79M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.6B | 0 | 466M | 471M | 550M | 599M | 489M | 376M | 435M | 392M | 395M | 426M | 507M | 372M | 421.81M | 351.66M | 353.94M | 332.13M | 729.03M | 601.36M | 296.74M | 295.36M | 0 | 0 | 0 | 0 | 0 | 29.32M | 15.8M | 17.6M | 0 |
| Current Ratio | 1.59x | 1.04x | 1.10x | 1.31x | 1.22x | 1.56x | 1.72x | 1.25x | 0.94x | 1.24x | 1.56x | 1.28x | 0.94x | 1.22x | 1.49x | 0.90x | 1.32x | 1.59x | 1.22x | 1.07x | 1.03x | 0.97x | 0.89x | 1.38x | 1.30x | 1.33x | 1.03x | 1.24x | 1.87x | 1.94x | 2.05x |
| Quick Ratio | 1.46x | 0.96x | 1.02x | 1.20x | 1.10x | 1.44x | 1.60x | 1.19x | 0.87x | 1.15x | 1.48x | 1.21x | 0.87x | 1.14x | 1.40x | 0.84x | 1.26x | 1.50x | 1.14x | 0.99x | 0.97x | 0.90x | 0.82x | 1.28x | 1.20x | 1.26x | 0.98x | 1.17x | 1.77x | 1.83x | 1.93x |
| Cash Conversion Cycle | 4.31 | -21.99 | 42.76 | 36.67 | 36.66 | 40.39 | 44.77 | 40.07 | 39.93 | 33.77 | 30.82 | 28.61 | 34.18 | 29.43 | 33.63 | 33.57 | 30.38 | 30.71 | 34.29 | 37.91 | 31.55 | 35.67 | -26.23 | -29.19 | -36 | -51.88 | -67.9 | -69.63 | -39.39 | -32.5 | 2.9 |
| Total Non-Current Liabilities | 7.25B | 6.66B | 7.09B | 5.79B | 5.28B | 5.3B | 5.36B | 5.09B | 4.17B | 4.41B | 4.38B | 4.01B | 3.84B | 3.84B | 4.05B | 4.04B | 3.26B | 3.49B | 3.57B | 3.95B | 1.49B | 1.44B | 871.35M | 1.18B | 919.36M | 935.95M | 877.75M | 1.31B | 482.8M | 564.1M | 606.91M |
| Long-Term Debt | 6.19B | 5.7B | 5.6B | 4.41B | 3.98B | 4.01B | 3.99B | 3.94B | 3.4B | 3.75B | 3.72B | 3.48B | 3.22B | 3.09B | 3.34B | 3.33B | 2.6B | 2.92B | 3.06B | 3.36B | 1.24B | 1.26B | 724.02M | 1.03B | 796.51M | 820.34M | 760.71M | 1.17B | 413.4M | 482.2M | 515.01M |
| Capital Lease Obligations | 1.65B | 537M | 551M | 503M | 489M | 494M | 524M | 443M | 32M | 0 | 7M | 13M | 21M | 31M | 18.21M | 37.79M | 39.45M | 20.27M | 14.82M | 17.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 250M | 270M | 295M | 290M | 350M | 264M | 243M | 170M | 191M | 157M | 204M | 192M | 187M | 184M | 193M | 0 | 0 | 0 | 21M | 22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.06B | 420M | 688M | 606M | 517M | 502M | 497M | 447M | 502M | 493M | 463M | 357M | 369M | 531M | 509.36M | 482.7M | 425.08M | 556.17M | 496.08M | 575.94M | 231.34M | 164.45M | 147.33M | 154.22M | 122.85M | 115.61M | 117.05M | 142.73M | 69.4M | 81.9M | 91.91M |
| Total Liabilities | 9.12B | 8.94B | 9.26B | 7.6B | 6.83B | 7.05B | 7.13B | 7.08B | 5.66B | 5.47B | 5.36B | 5.18B | 5.55B | 4.97B | 5.1B | 5.6B | 4.47B | 4.55B | 4.8B | 5.24B | 2.64B | 2.54B | 1.92B | 1.91B | 1.56B | 1.59B | 1.83B | 2.02B | 792.3M | 859.2M | 856.35M |
| Total Debt | 6.38B | 6.92B | 7.09B | 5.5B | 4.71B | 4.77B | 4.81B | 5.42B | 3.99B | 3.85B | 3.73B | 3.65B | 3.76B | 3.33B | 3.36B | 4.02B | 2.99B | 3.11B | 3.08B | 3.54B | 1.56B | 1.59B | 1.1B | 1.1B | 822.54M | 821.74M | 1.03B | 1.22B | 464.8M | 514.8M | 535.79M |
| Net Debt | 5.76B | 6.5B | 6.54B | 4.81B | 4.4B | 3.9B | 3.65B | 4.22B | 3.86B | 3.72B | 3.38B | 3.52B | 3.57B | 3.15B | 3.07B | 3.86B | 2.54B | 2.57B | 2.83B | 3.37B | 1.41B | 1.5B | 1.03B | 947.7M | 725.76M | 699.41M | 854.64M | 1.19B | 261.9M | 353.1M | 493.83M |
| Debt / Equity | 0.82x | 0.95x | 1.03x | 0.86x | 0.78x | 0.73x | 0.70x | 0.94x | 0.75x | 0.77x | 0.79x | 0.76x | 0.87x | 0.84x | 0.80x | 1.08x | 0.74x | 0.77x | 0.86x | 1.07x | 0.52x | 0.58x | 0.48x | 0.46x | 0.47x | 0.62x | 0.99x | 1.41x | 0.82x | 0.95x | 0.99x |
| Debt / EBITDA | 3.20x | 3.18x | 3.85x | 3.23x | 2.53x | 1.71x | 2.06x | 3.47x | 2.83x | 2.69x | 2.45x | 2.14x | 2.90x | 1.90x | 2.26x | 3.15x | 1.93x | 1.92x | 2.07x | 2.66x | 1.17x | 1.39x | 1.03x | 1.16x | 1.14x | 1.47x | 2.27x | 5.01x | 2.85x | 3.41x | - |
| Net Debt / EBITDA | 2.88x | 2.99x | 3.56x | 2.83x | 2.36x | 1.40x | 1.57x | 2.71x | 2.73x | 2.59x | 2.21x | 2.07x | 2.75x | 1.79x | 2.06x | 3.02x | 1.64x | 1.59x | 1.90x | 2.54x | 1.06x | 1.31x | 0.96x | 1.00x | 1.00x | 1.25x | 1.89x | 4.90x | 1.61x | 2.34x | - |
| Interest Coverage | 6.28x | 5.86x | 6.20x | 7.93x | 9.34x | 18.10x | 12.35x | 6.98x | 6.48x | 7.73x | 8.60x | 8.22x | 5.93x | 9.17x | 7.36x | 5.98x | 9.03x | 9.54x | 6.49x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 7.82B | 7.29B | 6.9B | 6.42B | 6.01B | 6.56B | 6.89B | 5.76B | 5.34B | 5.04B | 4.74B | 4.78B | 4.33B | 3.97B | 4.19B | 3.71B | 4.05B | 4.01B | 3.6B | 3.32B | 3.02B | 2.76B | 2.29B | 2.39B | 1.77B | 1.34B | 1.03B | 863.1M | 567.9M | 541.7M | 538.72M |
| Equity Growth % | 27.51% | 5.66% | 7.45% | 6.84% | -8.46% | -4.77% | 19.57% | 7.84% | 6.14% | 6.29% | -0.96% | 10.46% | 8.99% | -5.08% | 12.67% | -8.36% | 1.06% | 11.28% | 8.44% | 10.1% | 9.27% | 20.73% | -4.43% | 35.38% | 32.4% | 29.48% | 19.55% | 51.98% | 4.84% | 0.55% | - |
| Book Value per Share | 69.81 | 64.48 | 61.03 | 56.80 | 50.91 | 51.27 | 50.67 | 42.38 | 38.45 | 35.96 | 33.36 | 32.99 | 29.86 | 25.97 | 26.14 | 23.19 | 22.87 | 21.36 | 18.39 | 17.02 | 15.13 | 13.44 | 10.77 | 11.08 | 8.87 | 6.83 | 5.46 | 6.35 | 4.70 | 4.66 | 4.59 |
| Total Shareholders' Equity | 7.52B | 7.17B | 6.78B | 6.31B | 5.89B | 6.44B | 6.76B | 5.64B | 5.22B | 4.92B | 4.63B | 4.68B | 4.3B | 3.95B | 4.16B | 3.69B | 4.03B | 3.99B | 3.6B | 3.32B | 3.02B | 2.76B | 2.29B | 2.39B | 1.77B | 1.34B | 1.03B | 863.1M | 567.9M | 541.7M | 538.72M |
| Common Stock | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2.2M | 2.1M | 2.1M | 2.1M | 2.1M | 2.14M | 2.14M | 2.14M | 1.07M | 1.07M | 980K | 960K | 465K | 400K | 0 | 0 | 288K |
| Retained Earnings | 10.37B | 9.99B | 9.36B | 8.82B | 8.29B | 7.65B | 9.3B | 8.17B | 7.6B | 7.14B | 6.61B | 6.2B | 5.72B | 5.36B | 4.69B | 4.26B | 3.87B | 3.22B | 2.56B | 2.06B | 1.8B | 1.29B | 818.73M | 380.56M | -40.77M | -362.93M | -525.11M | -627M | -623.5M | -650.3M | -627.89M |
| Treasury Stock | -5.17B | -5.18B | -4.86B | -4.83B | -4.67B | -3.45B | -5.37B | -5.22B | -5B | -4.78B | -4.46B | -3.96B | -3.81B | -3.78B | -2.91B | -2.91B | -2.16B | -1.51B | -1.15B | -971.74M | -968.23M | -697.67M | -730.35M | -257.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -62M | -27M | -88M | -14M | -21M | -14M | -21M | -39M | -59M | -48M | -72M | -38M | -27M | -8M | 14.3M | -8M | 10.6M | -21M | -68.1M | 25.28M | -65K | -9.53M | 3.85M | 3.6M | -8.86M | -16.72M | -36.53M | -13.9M | -349.1M | -326.2M | -619K |
| Minority Interest | 303M | 116M | 118M | 111M | 114M | 118M | 132M | 122M | 128M | 114M | 109M | 99M | 29M | 25M | 22.7M | 22.1M | 20.6M | 21.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill impairment risk
Quest Diagnostics' total assets grew from $14.0B in 2024Q1 to $16.9B in 2026Q2, while debt-to-equity rose from 0.82 to 0.82, indicating expansion funded partly by debt, as per reported figures.
The balance sheet has expanded by approximately 20% over the period, driven by acquisitions and organic growth. However, the increase in total debt from $5.4B to $6.4B suggests that growth is partially debt-funded, which may increase financial risk if cash flows falter. The equity base has also grown steadily, supported by retained earnings, indicating a balanced approach to financing.
Debt-to-equity rose from 0.82 in 2024Q1 to 0.82 in 2026Q2, with total debt peaking at $7.0B in 2026Q1, according to SEC filings, suggesting increased reliance on debt for strategic moves.
The D/E ratio has remained relatively stable around 0.8-1.0, but the absolute debt level has increased by nearly $1B over the period. This appears to be strategic, supporting acquisitions that expand the asset base, as evidenced by the jump in goodwill from $7.8B to $9.1B. However, the recent reduction in debt from $7.0B to $6.4B in 2026Q2 indicates a deliberate deleveraging effort, which may signal management's focus on balance sheet strength.
Goodwill and intangibles constitute over half of total assets, rising from $7.8B in 2024Q1 to $9.1B in 2026Q2, as reported in financial statements, underscoring acquisition-driven growth and potential impairment exposure.
The asset mix is heavily weighted towards goodwill and intangibles, which now represent approximately 54% of total assets. This suggests that the company's growth strategy relies on acquisitions, which can be value-accretive but also carry impairment risk if expected synergies fail to materialize. PPE has grown modestly from $2.4B to $2.9B, indicating a relatively asset-light operational model, but the substantial goodwill balance warrants close monitoring for any signs of impairment.
Equity increased from $6.4B in 2024Q1 to $7.5B in 2026Q2, with retained earnings growing from $8.9B to $10.4B, as per reported data, indicating strong internal capital generation.
The growth in equity is primarily attributable to retained earnings, which have increased by $1.5B over the period, reflecting consistent profitability. This suggests that the company is reinvesting earnings to support growth and maintain a healthy equity buffer. However, the company also returns capital to shareholders via dividends and buybacks, which may moderate equity growth, but the overall trend indicates a strengthening equity base.
Current ratio improved from 0.97 in 2024Q1 to 1.59 in 2026Q2, while cash rose from $474M to $626M, according to financial statements, indicating a stronger short-term buffer.
The current ratio has improved significantly, moving from below 1.0 to 1.59, which suggests that the company now has sufficient current assets to cover its short-term obligations. Cash balances have also increased, providing a cushion against operational shocks. However, the absolute cash position of $626M is modest relative to total debt of $6.4B, implying that the company relies on operating cash flows and access to credit markets for liquidity, which could be a vulnerability in a downturn.
With goodwill at $9.1B, representing over half of total assets, any impairment would significantly impact equity and earnings, as per balance sheet data, posing a non-obvious risk.
The substantial goodwill balance, accumulated through acquisitions, is a key risk that may not be fully reflected in headline leverage metrics. If the acquired businesses underperform, the company may be required to record impairment charges, which would reduce equity and net income. This risk is particularly relevant given the recent acquisition activity and the potential for integration challenges. Investors should monitor the performance of acquired entities and any indicators of impairment, such as declining cash flows or market conditions.
Quick answers to the most common questions about buying DGX stock.
As of 2025, Quest Diagnostics Incorporated (DGX) had total assets of $16.23B including $2.38B in current assets.
Quest Diagnostics Incorporated (DGX) carries total debt of $6.92B, offset by $420.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Quest Diagnostics Incorporated (DGX) has total shareholders' equity (book value) of $7.17B ($64.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Quest Diagnostics Incorporated (DGX) reported a current ratio of 1.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.